Covidien and GE
Healthcare, leading global providers of healthcare products and recognized
innovators in patient monitoring and respiratory care devices, today announced
a five-year, global collaboration to incorporate Covidien measurement
technologies into GE Healthcare patient monitors.
“GE Healthcare is committed to making a broad range of
parameter measurements available on our powerful monitoring technology,
including GE’s own SpO2 technology,” said Matthias Weber, General Manager,
Monitoring Solutions at GE Healthcare. “Leveraging our 100-year history of
designing life-critical devices, we are focused on delivering innovative
clinical measurement technology. Such advances have the potential to support
improved care, quality, and patient safety.”
The Nellcor™ Respiratory Function portfolio, which includes
Nellcor pulse oximetry with OxiMax™ Technology, and the BIS™ Brain Monitoring
system, are now available on many GE Healthcare patient monitors. This includes
the CARESCAPE™ Monitor B850 and CARESCAPE™ Monitor B650, which combine GE
Healthcare’s strong cardiac and anesthesiology heritage.
The Covidien collaboration reflects GE Healthcare’s
commitment to maintain an open monitoring architecture, bringing together
streams of patient data and making it usable for clinicians at the point of
care. For instance, the CARESCAPE™ Monitor B850 now provides access to Covidien
measurements, bi-directional information flows between the monitor and hospital
information systems, such as electronic medical records, and electrocardiogram
measurements without requiring a separate monitor. Integrated clinical
information can provide valuable information for physicians, helping guide
their decisions and enhance efficiency of care.
“The advanced parameter portfolio from Covidien, coupled
with GE Healthcare’s patient monitors, supports clinicians in detecting subtle
but critical variations in a patient’s status,” says Robert J. White, President
of Covidien Respiratory and Monitoring Solutions. “By delivering the full
picture of a patient’s physiological status, patient safety and positive
outcomes can be advanced.”
The collaboration leverages the Covidien portfolio of
patient monitoring technologies, including:
Nellcor pulse oximetry with OxiMax Technology, a
cardiac-based pulse oximetry platform, which accurately monitors patients at
all acuity levels and in challenging conditions. The Nellcor pulse oximetry
solution from Covidien offers SpO2, Pulse Rate and Respiration Rate in a single
INVOS™ Cerebral/Somatic Oximetry which monitors
site-specific oxygen levels to optimize end-organ perfusion and help protect
against devastating major organ morbidity and neurological injury.
BIS Brain Monitoring which measures the effects of anesthetics
and sedatives on the brain.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in three
segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011
revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than
65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business. Nellcor, BIS, OxiMax and INVOS are
trademarks of Covidien in the U.S.
and foreign countries.
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical
imaging and information technologies, medical diagnostics, patient monitoring
systems, drug discovery, biopharmaceutical manufacturing technologies,
performance improvement and performance solutions services help our
customers to deliver better care to more people around the world at a
lower cost. In addition, we partner with healthcare leaders, striving
to leverage the global policy change necessary to implement a
successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the
world to join us on our journey as we continuously develop innovations
focused on reducing costs, increasing access and improving quality around
the world. Headquartered in the United
Kingdom, GE Healthcare is a unit of General
Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are
committed to serving healthcare professionals and their patients in more than
100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
CARESCAPE is a trademark of General Electric Company.